February 2026 — BioDuro has once again been honored with the 2025 Best CRO Award by Daewoong Pharmaceutical, recognizing its excellence among within Daewoong's global network of CRO partners. This repeat recognition reflects Daewoong Pharmaceutical's strong confidence in BioDuro's consistent scientific quality and project delivery.
Over the past year, BioDuro has worked closely with Daewoong Pharmaceutical across multiple innovative drug discovery programs, supporting key pipelines through its experienced chemistry teams and integrated technology platforms.
During the collaboration, Chemone, as a long-standing partner, contributed to project coordination and communication, helping support the smooth progress of joint programs.
As a global CRDMO partner, BioDuro remains committed to delivering integrated solutions spanning drug discovery, development, scale-up, and manufacturing. The company will continue to strengthen long-term collaborations worldwide to accelerate the development of innovative therapies for patients.
Home
